Norway
· Delayed Price · Currency is NOK PCI Biotech Holding ASA Statistics
Total Valuation
OSL:PCIB has a market cap or net worth of NOK 69.05 million. The enterprise value is 42.70 million.
| Market Cap | 69.05M |
| Enterprise Value | 42.70M |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:PCIB has 37.33 million shares outstanding.
| Current Share Class | 37.33M |
| Shares Outstanding | 37.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 3.73% |
| Owned by Institutions (%) | 14.72% |
| Float | 30.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.25 |
| PB Ratio | 2.94 |
| P/TBV Ratio | 2.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.60 |
| EV / Sales | 6.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.98 |
| Quick Ratio | 3.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -304.32 |
Financial Efficiency
Return on equity (ROE) is -52.54% and return on invested capital (ROIC) is -35.54%.
| Return on Equity (ROE) | -52.54% |
| Return on Assets (ROA) | -29.82% |
| Return on Invested Capital (ROIC) | -35.54% |
| Return on Capital Employed (ROCE) | -76.56% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -3.28M |
| Employee Count | 5 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.00% in the last 52 weeks. The beta is 1.81, so OSL:PCIB's price volatility has been higher than the market average.
| Beta (5Y) | 1.81 |
| 52-Week Price Change | +5.00% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 66.54 |
| Average Volume (20 Days) | 58,001 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:PCIB had revenue of NOK 6.74 million and -16.42 million in losses. Loss per share was -0.44.
| Revenue | 6.74M |
| Gross Profit | 6.74M |
| Operating Income | -17.96M |
| Pretax Income | -16.42M |
| Net Income | -16.42M |
| EBITDA | -17.65M |
| EBIT | -17.96M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 26.69 million in cash and 336,000 in debt, giving a net cash position of 26.36 million or 0.71 per share.
| Cash & Cash Equivalents | 26.69M |
| Total Debt | 336,000 |
| Net Cash | 26.36M |
| Net Cash Per Share | 0.71 |
| Equity (Book Value) | 23.45M |
| Book Value Per Share | 0.63 |
| Working Capital | 23.14M |
Cash Flow
| Operating Cash Flow | -13.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -266.59% and -243.76%.
| Gross Margin | 100.00% |
| Operating Margin | -266.59% |
| Pretax Margin | -243.76% |
| Profit Margin | -243.76% |
| EBITDA Margin | -262.09% |
| EBIT Margin | -266.59% |
| FCF Margin | n/a |
Dividends & Yields
OSL:PCIB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -23.77% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |